KR20100102890A - Process of manufacture of ability drink that use medicinal plant extraction liquid - Google Patents
Process of manufacture of ability drink that use medicinal plant extraction liquid Download PDFInfo
- Publication number
- KR20100102890A KR20100102890A KR1020090021183A KR20090021183A KR20100102890A KR 20100102890 A KR20100102890 A KR 20100102890A KR 1020090021183 A KR1020090021183 A KR 1020090021183A KR 20090021183 A KR20090021183 A KR 20090021183A KR 20100102890 A KR20100102890 A KR 20100102890A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- extract
- mixture
- green tea
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 21
- 238000000605 extraction Methods 0.000 title claims description 17
- 238000000034 method Methods 0.000 title description 3
- 239000007788 liquid Substances 0.000 title 1
- 239000000284 extract Substances 0.000 claims abstract description 82
- 239000000203 mixture Substances 0.000 claims abstract description 70
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000008213 purified water Substances 0.000 claims abstract description 28
- 244000269722 Thea sinensis Species 0.000 claims abstract description 23
- 235000009569 green tea Nutrition 0.000 claims abstract description 23
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 22
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 22
- 238000002156 mixing Methods 0.000 claims abstract description 20
- 239000000419 plant extract Substances 0.000 claims abstract description 20
- 230000001954 sterilising effect Effects 0.000 claims abstract description 18
- 244000236655 Diospyros kaki Species 0.000 claims abstract description 14
- 235000013361 beverage Nutrition 0.000 claims abstract description 14
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 11
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims abstract description 11
- 229960003080 taurine Drugs 0.000 claims abstract description 11
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 11
- 239000011718 vitamin C Substances 0.000 claims abstract description 11
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 9
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 9
- 238000011049 filling Methods 0.000 claims abstract description 6
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 34
- 241000736199 Paeonia Species 0.000 claims description 34
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 34
- 244000019194 Sorbus aucuparia Species 0.000 claims description 32
- 235000006414 serbal de cazadores Nutrition 0.000 claims description 30
- 235000020510 functional beverage Nutrition 0.000 claims description 22
- 229940094952 green tea extract Drugs 0.000 claims description 17
- 235000020688 green tea extract Nutrition 0.000 claims description 17
- 229940027779 persimmon extract Drugs 0.000 claims description 17
- 238000001914 filtration Methods 0.000 claims description 16
- 235000011511 Diospyros Nutrition 0.000 claims description 15
- 238000004659 sterilization and disinfection Methods 0.000 claims description 15
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 14
- 235000013399 edible fruits Nutrition 0.000 claims description 11
- 239000000796 flavoring agent Substances 0.000 claims description 11
- 235000019634 flavors Nutrition 0.000 claims description 11
- 229920000642 polymer Polymers 0.000 claims description 10
- 108010059892 Cellulase Proteins 0.000 claims description 9
- 229940106157 cellulase Drugs 0.000 claims description 9
- 229920001100 Polydextrose Polymers 0.000 claims description 7
- 239000001259 polydextrose Substances 0.000 claims description 7
- 235000013856 polydextrose Nutrition 0.000 claims description 7
- 229940035035 polydextrose Drugs 0.000 claims description 7
- 239000004382 Amylase Substances 0.000 claims description 6
- 108010065511 Amylases Proteins 0.000 claims description 6
- 102000013142 Amylases Human genes 0.000 claims description 6
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims description 6
- 102100022624 Glucoamylase Human genes 0.000 claims description 6
- 239000009724 Salvia extract Substances 0.000 claims description 6
- 235000019418 amylase Nutrition 0.000 claims description 6
- 235000017276 Salvia Nutrition 0.000 claims description 5
- 235000009508 confectionery Nutrition 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 240000007164 Salvia officinalis Species 0.000 claims description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
- 108010059820 Polygalacturonase Proteins 0.000 claims description 3
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 3
- 235000020710 ginseng extract Nutrition 0.000 claims description 3
- 229940107131 ginseng root Drugs 0.000 claims description 3
- 241000208340 Araliaceae Species 0.000 claims description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 2
- 241001092391 Sorbus Species 0.000 claims description 2
- 235000009790 Sorbus aucuparia Nutrition 0.000 claims description 2
- 235000008434 ginseng Nutrition 0.000 claims description 2
- 235000008345 mountainash Nutrition 0.000 claims description 2
- 235000020712 soy bean extract Nutrition 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 abstract description 4
- 230000002255 enzymatic effect Effects 0.000 abstract description 3
- 230000007721 medicinal effect Effects 0.000 abstract description 3
- 238000007789 sealing Methods 0.000 abstract description 3
- 235000008597 Diospyros kaki Nutrition 0.000 abstract 1
- 240000005001 Paeonia suffruticosa Species 0.000 abstract 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 235000004489 Sorbus commixta Nutrition 0.000 abstract 1
- 241001115347 Sorbus commixta Species 0.000 abstract 1
- 241000001727 Tropicoporus linteus Species 0.000 abstract 1
- -1 polydentrose Substances 0.000 abstract 1
- 241000544066 Stevia Species 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 6
- 230000002292 Radical scavenging effect Effects 0.000 description 5
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000013376 functional food Nutrition 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000006851 antioxidant defense Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000003642 reactive oxygen metabolite Substances 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000005502 peroxidation Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000723267 Diospyros Species 0.000 description 1
- 244000055850 Diospyros virginiana Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010022653 Intestinal haemorrhages Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241001072909 Salvia Species 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/56—Flavouring or bittering agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/72—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/51—Concentration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/032—Citric acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0644—Taurine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/154—Water
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/208—Fungi extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/214—Tea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/28—Oligosaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/708—Vitamin C
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
Abstract
Description
본 발명은 기능성 음료 제조방법에 관한 것으로, 더욱 상세하게는 DPPH 라디컬 소거능 측정에 의해 항산화활성이 높은 약용식물을 선별하여 약용식물 추출액을 이용한 기능성 음료 제조방법에 관한 것이다.The present invention relates to a method for producing a functional beverage, and more particularly, to a method for producing a functional beverage using medicinal plant extracts by selecting medicinal plants with high antioxidant activity by measuring DPPH radical scavenging ability.
최근 들어 일반인들은 건강의 중요성에 대한 인식이 강화되고 있으며, 건강 관리를 위하여 일상에서 운동에 시간을 투여하여 각종 질병들의 유발을 개개인 스스로 미연에 방지하고 있으며, 특히 노화에 따른 관절염, 또는 각종 암 발생을 방지하기 위하여 운동을 하거나, 운동과 병행하여 알약 형태이거나 음료 형태로 제공되는 기능성 식품들을 섭취하고 있다.In recent years, the general public has become more aware of the importance of health and prevents the induction of various diseases by putting time on exercise in daily life for health care, and in particular, causes arthritis or various cancers due to aging. In order to prevent the exercise or in parallel with the exercise is taking a functional food that is provided in the form of a pill or drink.
여기서, 노화를 유발하거나 암을 발생시키는 원인 중 하나로는, 생체내에서 프리 라디칼(Free Radical) 반응에 의해 생성되는 활성산소종(ROS: reactive oxygen species)이 원인이 되고 있다.Here, one of the causes of aging or cancer is caused by reactive oxygen species (ROS) generated by a free radical reaction in vivo.
활성산소종은 DNA 분절과 단백질의 불활성화 및 세포 생체막의 구성 성분인 불포화지방산을 공격하여 과산화 반응을 일으켜 생체기능을 저하시킴으로서 노화를 유발하여 류마티스성 관절염 등의 질병의 원인이되고, 뿐만 아니라 당뇨병, 심장병, 동맥경화, 암 등과 같은 여러 질환의 원인으로 잘 알려져 있다.Active oxygen species induce DNA aging and protein inactivation and attack unsaturated fatty acids, which are components of cell membranes, and cause peroxidation to decrease biofunction, causing aging and causing diseases such as rheumatoid arthritis. It is well known for causing various diseases such as heart disease, arteriosclerosis, and cancer.
활성산소종은 상술한 바와 같이 여러 질환의 원인이 되고 있는데, 종래의 기능성 식품들은 단순히 약리효과만을 가질 뿐, 생체내의 과산화 반응을 억제할 수 없었다.As described above, reactive oxygen species cause various diseases, and conventional functional foods merely have a pharmacological effect and cannot inhibit peroxidation in vivo.
따라서 생체내에서 항산화 방어시스템을 증가시키거나 활성산소종을 조절할수 있는 기능성 식품들의 개발이 요구되고 있다.Therefore, the development of functional foods that can increase the antioxidant defense system or regulate free radical species in vivo.
따라서 본 발명이 해결하고자 하는 과제는, 약리효과를 가지면서 생체내에서 항산화 방어시스템을 증가시키거나 활성산소종을 조절할 수 있는 약용식물 추출액을 이용한 기능성 음료 제조방법을 제공하는데 있다.Therefore, the problem to be solved by the present invention, to provide a functional beverage production method using a medicinal plant extract that can increase the antioxidant defense system or regulate active oxygen species in vivo while having a pharmacological effect.
상술한 과제를 해결하기 위한 본 발명의 한 실시예에 따른 약용식물 추출액을 이용한 기능성 음료 제조방법은 녹차, 감나무, 모란, 단삼, 마가목, 상황버섯 각각을 열수 추출하는 추출단계; 상기 추출단계에서 얻어진 녹차 추출액, 감나무 추출액, 모란 추출액, 단삼 추출액, 상황버섯 추출액을 비타민 C, 프락토올리고당, 복합황금 추출물, 나한과 추출물, 타우린, 폴리덱스트로즈(중합체 90% 이상), 구연산, 효소처리 스테비아, 정제수와 혼합하여 음료 혼합물을 생성하는 혼합단계; 상기 음료 혼합물을 98℃의 온도에서 2~5분간 살균하는 살균단계; 상기 살균단계에서 살균된 상기 음료 혼합물을 용기에 충진하여 냉각한 후 캡으로 밀봉하는 충진단계를 포함한다.Functional beverage manufacturing method using a medicinal plant extract according to an embodiment of the present invention for solving the above problems is an extraction step of extracting each of the green tea, persimmon, peony, dansam, rowan, situation mushroom; The green tea extract, persimmon extract, peony extract, sweet ginseng extract, and situation mushroom extract obtained in the extraction step may be vitamin C, fructooligosaccharide, complex golden extract, Nahan fruit extract, taurine, polydextrose (90% or more of polymer), citric acid A mixing step of producing a beverage mixture by mixing with enzymatically treated stevia and purified water; A sterilization step of sterilizing the beverage mixture at a temperature of 98 ° C. for 2 to 5 minutes; And a filling step of sealing the beverage mixture sterilized in the sterilization step and then sealing the cap with a cap.
상기 추출단계에서 상기 녹차 추출액은, 정제수 3000 중량부에 대하여 상기 녹차 건조 잎 100 중량부를 혼합하여 녹차 혼합물을 생성하고, 상기 녹차 혼합물을 80℃의 온도에서 6시간 동안 가열하고, 상기 녹차 혼합물을 여과 및 농축하여 생성할 수 있다.In the extracting step, the green tea extract is mixed with 100 parts by weight of the green tea dry leaves with respect to 3000 parts by weight of purified water to produce a green tea mixture, the green tea mixture is heated at a temperature of 80 ° C. for 6 hours, and the green tea mixture is filtered. And concentrated.
상기 추출단계에서 상기 감나무 추출액은, 정제수 5000 중량부에 대하여 감 나무 건조 뿌리 100 중량부, 내열성 아밀라제 0.5 중량부를 혼합하여 감나무 혼합물을 생성하고, 상기 감나무 혼합물을 120℃의 온도에서 6시간 동안 가열하고, 상기 녹차 혼합물을 여과 및 농축하여 생성할 수 있다.In the extraction step, the persimmon extract is mixed with 100 parts by weight of persimmon tree dry root, 0.5 parts by weight of heat-resistant amylase with respect to 5000 parts by weight of purified water to produce a persimmon mixture, the persimmon mixture is heated at a temperature of 120 ℃ for 6 hours The green tea mixture may be produced by filtration and concentration.
상기 추출단계에서 상기 모란 추출액은, 정제수 8000 중량부에 대하여 모란 뿌리 껍질 100 중량부, 셀룰라제 0.3 중량부, 글루코아밀라제 0.3 중량부를 혼합하여 모란 혼합물을 생성하고, 상기 모란 혼합물을 50℃의 온도로 3시간 동안 가열하고, 상기 모란 혼합물을 여과 및 농축하여 생성할 수 있다.In the extraction step, the peony extract, by mixing 100 parts by weight of peony root shell, 0.3 parts by weight of cellulase, 0.3 parts by weight of glucoamylase with respect to 8000 parts by weight of purified water to form a peony mixture, the peony mixture at a temperature of 50 ℃ Heated for 3 hours and the peony mixture can be produced by filtration and concentration.
상기 추출단계에서 상기 단삼 추출액은, 정제수 5000 중량부에 대하여 단삼 건조 뿌리 100 중량부, 셀룰라제 0.3 중량부, 비스코자임 0.3 중량부를 혼합하여 단삼 혼합물을 생성하고, 상기 단삼 혼합물을 55℃의 온도로 3시간 동안 가열하고, 상기 단삼 혼합물을 여과 및 농축하여 생성할 수 있다.In the extraction step, the salvia extract is mixed with 100 parts by weight of dried ginseng root, 0.3 parts by weight of cellulase, and 0.3 parts by weight of biskozyme with respect to 5000 parts by weight of purified water to produce a mixture of soybeans, and the mixture of soybeans at a temperature of 55 ° C. Heated for 3 hours, the salvia mixture can be produced by filtration and concentration.
상기 추출단계에서 상기 마가목 추출액은, 정제수 1000 중량부에 대하여 마가목 열매 100 중량부, 비스코자임 0.3 중량부, 펙티나아제 0.6 중량부, 글루코아밀라제 0.2 중량부를 혼합하여 마가목 혼합물을 생성하고, 상기 마가목 혼합물을 55℃의 온도로 3시간 동안 가열하고, 상기 마가목 혼합물을 여과 및 농축하여 생성할 수 있다.In the extracting step, the mountain ash extract is mixed with 100 parts by weight of rowan fruit, 0.3 parts by weight of biscozyme, 0.3 parts by weight of pectinase, 0.2 parts by weight of glucoamylase, to produce a rowan mixture, the rowan mixture Can be produced by heating to a temperature of 55 ° C. for 3 hours and filtering and concentrating the rowan mixture.
상기 추출단계에서 상기 상황버섯 추출액은, 정제수 1200 중량부에 대하여 상황버섯 100 중량부, 내열성 아밀라제 0.5 중량부를 혼합하여 상황버섯 혼합물을 생성하고, 상기 상황버섯 혼합물을 120℃의 온도로 6시간 동안 1차 가열하고, 당화효소 0.3 중량부, 셀룰라제 0.3 중량부를 더 혼합하여 60℃의 온도에서 6시간 동안 2차 가열하고, 상기 상황버섯 혼합물을 여과 및 농축하여 생성할 수 있다.In the extraction step, the situation mushroom extract is mixed with 100 parts by weight of mushrooms, 0.5 parts by weight of heat-resistant amylase with respect to 1200 parts by weight of purified water to produce a situation mushroom mixture, the situation mushroom mixture for 1 hour at a temperature of 120 ℃ 1 After heating the mixture, 0.3 parts by weight of glycosylase and 0.3 parts by weight of cellulase may be further mixed for 2 hours at a temperature of 60 ° C., and the situation mushroom mixture may be produced by filtration and concentration.
상기 음료 혼합물을 생성하는 상기 혼합단계에서, 상기 녹차 추출액 1.5~2.6 중량부, 상기 감나무 추출액 0.7~1.6 중량부, 상기 모란 추출액 0.8~2.3 중량부, 상기 단삼 추출액 0.8~1.9 중량부, 상기 마가목 추출액 0.5~1.5 중량부, 상기 상황버섯 추출액 0.6~2.0 중량부, 비타민 C 0.05~1.7 중량부, 프락토 올리고당 8.0~11.0 중량부, 복합 황금추출물 0.01~0.1 중량부, 나한과 추출물 0.05~0.1 중량부, 타우린 0.04~0.06 중량부, 폴리텍스트로즈(중합체 90%) 0.5~2.5 중량부, 구연산 0.1~0.25 중량부, 효소처리 스테비아 0.35~0.5 중량부, 정제수 85.9~71.69 중량부가 혼합될 수 있다.In the mixing step to produce the beverage mixture, the green tea extract 1.5 ~ 2.6 parts by weight, the persimmon extract 0.7 ~ 1.6 parts by weight, the peony extract 0.8 ~ 2.3 parts by weight, the soybean extract 0.8 ~ 1.9 parts by weight, the rowan extract 0.5-1.5 parts by weight, 0.6-2.0 parts by weight of the above-mentioned mushroom extract, 0.05-1.7 parts by weight of vitamin C, 8.0-11.0 parts by weight of fructo oligosaccharide, 0.01-0.1 parts by weight of the complex golden extract, 0.05-0.1 parts by weight of the hanja extract , 0.04 to 0.06 parts by weight of taurine, 0.5 to 2.5 parts by weight of polytextrose (90% of polymer), 0.1 to 0.25 parts by weight of citric acid, 0.35 to 0.5 parts by weight of enzymatically treated stevia, and 85.9 to 71.69 parts by weight of purified water.
상기 살균단계 이후에 허브향 0.1~0.2 중량부를 더 혼합될 수 있다.After the sterilization step, the herbal flavor may be further mixed 0.1 to 0.2 parts by weight.
본 발명에 따른 약용식물 추출액을 이용한 기능성 음료 제조방법은, 항산화활성이 높은 약용식물을 선별 및 열수추출하여 약용식물이 가지는 효능에 의한 약리효과를 가지며, 생체내에서 항산화 방어시스템을 증가시키거나 활성산소종을 조절할 수 있는 기능성 음료를 제조할 수 있는 효과가 있다.Functional beverage preparation method using the medicinal plant extract according to the present invention, has a pharmacological effect by the efficacy of medicinal plants by screening and extracting hot water medicinal plants with high antioxidant activity, increase the antioxidant defense system in vivo or active There is an effect that can produce a functional beverage that can control the oxygen species.
기타 실시예의 구체적인 사항들은 상세한 설명 및 도면들에 포함되어 있다.Specific details of other embodiments are included in the detailed description and drawings.
본 발명의 이점 및 특징, 그리고 그것들을 달성하는 방법은 첨부되는 도면과 함께 상세하게 후술되어 있는 실시예를 참조하면 명확해질 것이다.Advantages and features of the present invention, and methods for achieving them will be apparent with reference to the embodiments described below in detail in conjunction with the accompanying drawings.
그러나 본 발명은 이하에서 개시되는 실시예에 한정되는 것이 아니라 서로 다른 다양한 형태로 구현될 것이며, 단지 본 실시예는 본 발명의 개시가 완전하도록 하며, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 발명의 범주를 완전하게 알려주기 위해 제공되는 것이며, 본 발명은 청구항의 범주에 의해 정의될 뿐이다.However, the present invention is not limited to the embodiments disclosed below, but will be implemented in various forms, and only the present embodiments are intended to complete the disclosure of the present invention, and those skilled in the art to which the present invention pertains. It is provided to fully inform the scope of the invention, and the invention is defined only by the scope of the claims.
이하, 첨부된 도면을 참조로 하여 본 발명에 따른 약용식물 추출액을 이용한 기능성 음료 제조방법 대하여 상세히 설명한다.Hereinafter, with reference to the accompanying drawings will be described in detail a functional beverage manufacturing method using the medicinal plant extract according to the present invention.
도 1은 본 발명의 한 실시예에 따른 약용식물 추출액을 이용한 기능성 음료 제조방법의 제조 단계를 나타낸 블록도로써, 도 1을 참조하면 본 발명의 한 실시예에 따른 약용식물 추출액을 이용한 기능성 음료 제조방법는 추출단계(S101), 혼합단계(S102), 살균단계(S103), 충진단계(S105)를 포함한다.1 is a block diagram showing the manufacturing steps of a functional beverage manufacturing method using a medicinal plant extract according to an embodiment of the present invention, referring to Figure 1 manufacturing a functional beverage using a medicinal plant extract according to an embodiment of the present invention The method includes an extraction step S101, a mixing step S102, a sterilization step S103, and a filling step S105.
추출단계(S101)에서는, 녹차, 감나무, 모란, 단삼, 마가목, 상황버섯을 포함하여 총 30여종의 약용식물 및 한약재 소재를 분해효소를 활용한 열수추출하였고, 그 중 DPPH 라디칼 소거능 측정을 통해 가장 활성도가 높은 녹차 추출액, 감나무 추출액, 모란 추출액, 단삼 추출액, 마가목 추출액, 상황버섯 추출액을 선별하였다.In the extraction step (S101), a total of 30 kinds of medicinal plants and herbal medicines including green tea, persimmon, peony, dansam, rowan, and situation mushrooms were extracted by using hydrolytic enzymes, and the most measured by DPPH radical scavenging ability. High activity green tea extract, persimmon extract, peony extract, Dansam extract, rowan extract, and situation mushroom extract were selected.
이때, 상기 나열된 약용식물들은 녹차의 건조 잎, 감나무의 건조 뿌리, 모란의 뿌리 껍질, 단삼의 건조 뿌리, 마가목의 열매, 상황버섯 그 자체를 사용하였으며, 각 소재들은 마가목의 열매를 제외하고는 분쇄하여 사용하였다.At this time, the medicinal plants listed above used dried leaves of green tea, dried roots of persimmon tree, roots of peonies, dried roots of red ginseng, fruits of rowan, and situation mushrooms themselves, and each material was ground except for the fruits of rowan Was used.
DPPH 라디칼 소거능 측정방법은, 각 추출액 시료 1.0mg을 에탄올(ethanol) 1.0mL에 용해하여 사용하였다. 그리고 각 시료 용액 100㎕를 시험관에 첨가한 후 에탄올 4.0mL를 넣고 2×10-4M DPPH용액 1.0 mL을 가한 후 보르텍스 믹서(vortex mixer)로 교반하였고, 실온에서 30분간 반응시키고 517nm에서 흡광도를 측정하여 DPPH 라디칼(radical) 소거능(%)을 확인하였다. 실험결과는 다음의 표 1과 같다.In the DPPH radical scavenging activity measurement method, 1.0 mg of each extract sample was dissolved in 1.0 mL of ethanol and used. Then, 100 μl of each sample solution was added to the test tube, 4.0 mL of ethanol was added, 1.0 mL of 2 × 10 -4 M DPPH solution was added thereto, and the resultant was stirred with a vortex mixer, reacted at room temperature for 30 minutes, and absorbed at 517 nm. Was measured to confirm the DPPH radical scavenging ability (%). The experimental results are shown in Table 1 below.
[표 1]TABLE 1
DPPH 라디칼 소거능 측정에서 녹차 추출액, 감나무 추출액, 모란 추출액, 단삼 추출액, 마가목 추출액, 상황버섯 추출액 이외의 추출액들은 10% 미만의 수치를 나타내었다.In the DPPH radical scavenging activity, extracts other than green tea extract, persimmon extract, peony extract, sweet ginseng extract, rowan extract, and mushroom extract showed less than 10%.
여기서, 선별된 각 추출액들의 열수추출 조건을 상세히 설명하면 다음과 같다.Here, the hot water extraction conditions of each of the selected extracts will be described in detail.
녹차 추출액은, 정제수 3000g에 대하여 녹차 건조 잎 100g를 혼합하여 녹차 혼합물을 생성하고, 녹차 혼합물을 80℃의 온도에서 6시간 동안 가열하고, 가열된 녹차 혼합물을 여과 및 농축(Brix50)하여 생성하였다.The green tea extract was produced by mixing 100 g of green tea dried leaves with 3000 g of purified water to produce a green tea mixture, heating the green tea mixture at a temperature of 80 ° C. for 6 hours, and filtering and concentrating the heated green tea mixture (Brix50).
감나무 추출액은, 정제수 5000g에 대하여 감나무 건조 뿌리 100g, 내열성 아밀라제(α- amylase) 0.5g을 혼합하여 감나무 혼합물을 생성하고, 감나무 혼합물을 120℃의 온도에서 6시간 동안 가열하고, 녹차 혼합물을 여과 및 농축(Brix50)하여 생성하였다.Persimmon extract is mixed with 100 g of dried persimmon root and 0.5 g of heat-resistant amylase to 5000 g of purified water to produce a persimmon mixture, the persimmon mixture is heated at a temperature of 120 ° C. for 6 hours, and the green tea mixture is filtered and Produced by concentration (Brix50).
모란 추출액은, 정제수 8000g에 대하여 모란 뿌리 껍질 100g, 셀룰라 제(Cellulase) 0.3g, 글루코아밀라제(Glucoamylase) 0.3g을 혼합하여 모란 혼합물을 생성하고, 모란 혼합물을 50℃의 온도로 3시간 동안 가열하고, 가열된 모란 혼합물을 여과 및 농축하여 생성하였다.The peony extract is mixed with 100 g of peony root shell, 0.3 g of Cellulase, and 0.3 g of Glucoamylase to 8000 g of purified water to form a peony mixture, and the peony mixture is heated to a temperature of 50 ° C. for 3 hours. The heated peony mixture was produced by filtration and concentration.
단삼 추출액은, 정제수 5000g에 대하여 단삼 건조 뿌리 100g, 셀룰라제(Cellulase) 0.3g, 비스코자임(Viscozyme) 0.3g을 혼합하여 단삼 혼합물을 생성하고, 단삼 혼합물을 55℃의 온도로 3시간 동안 가열하고, 가열된 단삼 혼합물을 여과 및 농축(Brix50)하여 생성하였다.Salvia extract was mixed with 100 g of dried ginseng root, 0.3 g of Cellulase 0.3 g, and 0.3 g of Viscozyme with respect to 5000 g of purified water to produce a salvia mixture, and the salvia mixture was heated to a temperature of 55 ° C. for 3 hours. The heated Sweet Ginseng mixture was produced by filtration and concentration (Brix50).
마가목 추출액은, 정제수 1000g에 대하여 마가목 열매 100g, 비스코자임(Viscozyme) 0.3g, 펙티나아제(Pectinase) 0.6g, 글루코아밀라제(Glucoamylase) 0.2g을 혼합하여 마가목 혼합물을 생성하고, 마가목 혼합물을 55℃의 온도로 3시간 동안 가열하고, 가열된 마가목 혼합물을 여과 및 농축(Brix50)하여 생성하였다.The rowan extract was prepared by mixing 100 g of rowan berries, 0.3 g of Viscozyme, 0.6 g of Pectinase, and 0.2 g of Glucoamylase with respect to 1000 g of purified water to produce a rowan mixture, and the rowan mixture was 55 ° C. Heated to a temperature of 3 h and the heated rowan mixture was produced by filtration and concentration (Brix50).
상황버섯 추출액은, 정제수 1200g에 대하여 상황버섯 100g, 내열성 아밀라제(α- amylase) 0.5g을 혼합하여 상황버섯 혼합물을 생성하고, 상황버섯 혼합물을 120℃의 온도로 6시간 동안 1차 가열하고, 당화효소 0.3g, 셀룰라제(Cellulase) 0.3g을 더 혼합하여 60℃의 온도에서 6시간 동안 2차 가열하고, 2차 가열된 상황버섯 혼합물을 여과 및 농축(Brix50)하여 생성하였다.The situation mushroom extract was mixed with 100 g of purified mushrooms and 0.5 g of heat-resistant amylase (α-amylase) to 1200 g of purified water to produce a situation mushroom mixture, and the situation mushroom mixture was first heated at a temperature of 120 ° C. for 6 hours, and saccharified. 0.3 g of enzyme and 0.3 g of Cellulase were further mixed, followed by secondary heating at a temperature of 60 ° C. for 6 hours, and the secondary heated situation mushroom mixture was produced by filtration and concentration (Brix50).
이와 같은 열수추출 조건으로 추출된 추출액들은 약용 효능을 가지는데, 녹차 잎은 녹차의 원료로 사용되는 약용식물이다. 녹차는 카테긴, 데아닌, 탄닌, 카페인과 아미노산 등이 많이 함유되어 있어 기능성 식품으로서 콜레스테롤 저하 및 약리효과가 다양하고 폴리페놀 성분 등이 들어 있어 건강식품으로도 널리 애용되고 있으며, 고혈압, 당뇨병 등의 성인병 예방과 산화지방 등에 탁월한 효능을 나타내고 있다.Extracts extracted under such hot water extraction conditions have medicinal efficacy, and green tea leaves are medicinal plants used as raw materials of green tea. Green tea is rich in catechin, deanine, tannin, caffeine and amino acids. As a functional food, it has various cholesterol lowering and pharmacological effects, and it is widely used as a health food because it contains polyphenols. It is effective in preventing adult diseases and oxidized fat.
감나무는 잎, 열매, 뿌리들을 약용 재료로 사용하고 있으며, 특히 감나무의 뿌리는 그 맛이 떫으며 성질은 평하고 독이 없다. 효능으로는 혈을 식히고 지혈하는 효능이 있으며, 혈붕, 혈리, 적리, 하혈, 토혈, 치질을 치료하는 효능을 나타내고 있다.Persimmon trees use leaves, berries, and roots as medicinal ingredients. Especially, the roots of persimmons have a good taste and have a flat and nonpoisonous nature. Efficacy is the effect of cooling blood and hemostasis, and has been shown to cure blood shelf, hemolysis, erythema, bleeding, hemorrhage, hemorrhoids.
모란은 뿌리 껍질을 말린 목단피를 약재로 사용하며, 한방에서는 소염, 진통, 정혈, 고혈압 등에 쓰이고 있으며, 해열, 양혈, 화혈, 소어의 효능이 있고 열입혈, 분증, 발반, 경간 등을 치료하는 효능을 나타내고 있다.Peony uses dried bark skin as a medicinal herb, and is used for anti-inflammatory, analgesic, bleeding, and high blood pressure in Korean medicine. Indicates.
단삼 뿌리는 특이한 냄새가 나고 약간 쓴맛이 나며 한방에서 약재로 쓰인다. 효능으로는 혈액순환을 돕고 어혈을 제거하며 사지관절 동통을 완화시키는 등 많은 약용 효능을 가지며, 약리작용으로는 관상동맥 확장, 콜레스테롤 강하, 혈압 강하, 간기능 활성화, 진정 항염, 항암, 항균작용 등을 나타내고 있다.Salvia root has a peculiar smell, has a bitter bitter taste, and is used as a medicine in Chinese medicine. Efficacy has many medicinal effects such as blood circulation, removes blood, and alleviates limb pain. Pharmacological action is coronary artery expansion, cholesterol lowering, blood pressure lowering, liver function activation, soothing anti-inflammatory, anti-cancer, antibacterial effect, etc. Indicates.
마가목은 주로 열매 및 껍질을 채취하여 약으로 쓰고 있으며, 마가목은 류마티스 관절염, 신경통, 기침 등에 좋은 효력이 있다.Rowan is mainly used to extract the fruit and bark as a medicine, rowan has a good effect on rheumatoid arthritis, neuralgia, cough.
상황버섯은 자궁출혈 및 대하, 월경불순, 장출혈, 위장기능 활성화에 많이 이용되고 있으며, 위암, 식도암, 십이지장암, 결장암, 직장암, 간암 등에 효과를 나타내는 항암효과가 우수하다.Situation mushrooms are widely used for uterine bleeding and stool, dysmenorrhea, intestinal bleeding, and gastrointestinal function activation.
따라서, 녹차 추출액, 감나무 추출액, 모란 추출액, 단삼 추출액, 마가목 추출액, 상황버섯 추출액은 항산화활성 우수하고, 상술한 약용 효능들을 가질 수 있 다.Therefore, green tea extract, persimmon extract, peony extract, Dansam extract, rowan extract, situation mushroom extract has excellent antioxidant activity and may have the above medicinal effects.
혼합단계(S102)에서는, 녹차 추출액 1.5g~2.6g, 감나무 추출액 0.7g~1.6g, 모란 추출액 0.8g~2.3g, 단삼 추출액 0.8g~1.9g, 마가목 추출액 0.5g~1.5g, 상황버섯 추출액 0.6g~2.0g, 비타민 C 0.05g~1.7g, 프락토 올리고당(FOS) 8.0g~11.0g, 복합 황금추출물 0.01g~0.1g, 나한과 추출물 0.05g~0.1g, 타우린 0.04g~0.06g, 폴리텍스트로즈(중합체 90% 이상) 0.5g~2.5g, 구연산 0.1g~0.25g, 효소처리 스테비아 0.35g~0.5g, 정제수 85.9g~71.69g를 혼합하여 음료 혼합물을 생성한다.In the mixing step (S102), green tea extract 1.5g ~ 2.6g, persimmon extract 0.7g ~ 1.6g, peony extract 0.8g ~ 2.3g, salvia extract 0.8g ~ 1.9g, rowan extract 0.5g ~ 1.5g, situation mushroom extract 0.6g ~ 2.0g, Vitamin C 0.05g ~ 1.7g, Fructo Oligosaccharides (FOS) 8.0g ~ 11.0g, Complex Golden Extract 0.01g ~ 0.1g, Nahan Fruit Extract 0.05g ~ 0.1g, Taurine 0.04g ~ 0.06g , 0.5 g to 2.5 g of polytextrose (90% or more of polymer), 0.1 g to 0.25 g of citric acid, 0.35 g to 0.5 g of enzymatically treated stevia, and 85.9 g to 71.69 g of purified water are mixed to form a beverage mixture.
살균단계(S103)에서는, 음료 혼합물을 98℃의 온도에서 2~5분간 살균한다. 그리고 살균이 완료되면 음료 혼합물에 허브향 0.1g~0.2g을 첨가한다(S104).In the sterilization step (S103), the beverage mixture is sterilized for 2 to 5 minutes at a temperature of 98 ℃. And when the sterilization is complete, add 0.1g ~ 0.2g herbal flavor to the beverage mixture (S104).
충진단계(S105)에서는, 살균단계에서 살균되고 허브향이 첨가된 음료 혼합물을 용기에 충진하여 냉각한 후 캡으로 밀봉한다.In the filling step (S105), the beverage mixture sterilized in the sterilization step and the herbal flavor is added to the container, cooled and sealed with a cap.
이하에서는 혼합단계에서 혼합되는 각 성분들의 혼합비를 달리하는 실시예들을 설명한다.Hereinafter, embodiments of varying the mixing ratio of each component mixed in the mixing step will be described.
<실시예 1>≪ Example 1 >
혼합단계에서 녹차 추출액 1.5g, 감나무 추출액 1.6g, 모란 추출액 2.0g, 단삼 추출액 0.8g, 마가목 추출액 0.7g, 상황버섯 추출액 0.6g, 비타민 C 0.1g, 프락토 올리고당 10.0g, 복합 황금추출물 0.05g, 나한과 추출물 0.07g, 타우린 0.05g, 폴리덱스트로즈(중합체 90% 이상) 0.5g, 구연산 0.15g, 효소처리 스테비아 0.5g, 정제수 81.28g을 혼합하고, 살균단계 이후에 허브향 0.1g을 혼합하여 기능성 음료를 제조하였다.Green tea extract 1.5g, persimmon extract 1.6g, peony extract 2.0g, red ginseng extract 0.8g, rowan extract 0.7g, green mushroom extract 0.6g, vitamin C 0.1g, fructo oligosaccharide 10.0g, complex golden extract 0.05g , Nagwa fruit extract 0.07g, taurine 0.05g, polydextrose (polymer 90% or more) 0.5g, citric acid 0.15g, enzymatic stevia 0.5g, purified water 81.28g, after the sterilization step 0.1g herbal flavor Functional drinks were prepared by mixing.
<실시예 2><Example 2>
혼합단계에서 녹차 추출액 2g, 감나무 추출액 1.5g, 모란 추출액 2.3g, 단삼 추출액 1.2g, 마가목 추출액 0.5g, 상황버섯 추출액 0.7g, 비타민 C 0.05g, 프락토 올리고당 8.7g, 복합 황금추출물 0.05g, 나한과 추출물 0.07g, 타우린 0.05g, 폴리덱스트로즈(중합체 90% 이상) 1.5g, 구연산 0.18g, 효소처리 스테비아 0.35g, 정제수 80.65g을 혼합하고, 살균단계 이후에 허브향 0.2g을 혼합하여 기능성 음료를 제조하였다.In the mixing step, green tea extract 2g, persimmon extract 1.5g, peony extract 2.3g, Dansam extract 1.2g, rowan extract 0.5g, situation mushroom extract 0.7g, vitamin C 0.05g, fructo oligosaccharide 8.7g, complex golden extract 0.05g, Nagwa fruit extract 0.07g, taurine 0.05g, polydextrose (more than 90% polymer) 1.5g, citric acid 0.18g, enzymatically treated stevia 0.35g, purified water 80.65g, after the sterilization step mixed 0.2g herbal flavor To prepare a functional beverage.
<실시예 3><Example 3>
혼합단계에서 녹차 추출액 2.6g, 감나무 추출액 0.7g, 모란 추출액 0.8g, 단삼 추출액 1.6g, 마가목 추출액 1g, 상황버섯 추출액 1g, 비타민 C 1.5g, 프락토 올리고당 8.0g, 복합 황금추출물 0.01g, 나한과 추출물 0.05g, 타우린 0.05g, 폴리덱스트로즈(중합체 90% 이상) 1.0g, 구연산 0.25g, 효소처리 스테비아 0.5g, 정제수 80.74g을 혼합하고, 살균단계 이후에 허브향 0.2g을 혼합하여 기능성 음료를 제조하였다.Green tea extract 2.6g, persimmon extract 0.7g, peony extract 0.8g, Dansam extract 1.6g, rowan extract 1g, situation mushroom extract 1g, vitamin C 1.5g, fructo oligosaccharide 8.0g, complex golden extract 0.01g, Nahan And extract 0.05g, taurine 0.05g, polydextrose (more than 90% polymer) 1.0g, citric acid 0.25g, enzymatic stevia 0.5g, purified water 80.74g, after the sterilization step 0.2g of herbal flavors were mixed Functional drinks were prepared.
<실시예 4><Example 4>
혼합단계에서 녹차 추출액 1.0g, 감나무 추출액 1.6g, 모란 추출액 2.0g, 단삼 추출액 1.9g, 마가목 추출액 0.5g, 상황버섯 추출액 1g, 비타민 C 1.7g, 프락토 올리고당 9.0g, 복합 황금추출물 0.05g, 나한과 추출물 0.1g, 타우린 0.05g, 폴리덱스트로즈(중합체 90% 이상) 2.0g, 구연산 0.2g, 효소처리 스테비아 0.1g, 정제수 78.7g을 혼합하고, 살균단계 이후에 허브향 0.1g을 혼합하여 기능성 음료를 제조하 였다.In the mixing step, green tea extract 1.0g, persimmon extract 1.6g, peony extract 2.0g, salvia extract 1.9g, rowan extract 0.5g, situation mushroom extract 1g, vitamin C 1.7g, fructo oligosaccharide 9.0g, complex golden extract 0.05g, Nagwa fruit extract 0.1g, taurine 0.05g, polydextrose (more than 90% of polymer) 2.0g, citric acid 0.2g, enzyme-treated stevia 0.1g, purified water 78.7g, after the sterilization step mixed with 0.1g herbal flavor To prepare a functional beverage.
<실시예 5><Example 5>
혼합단계에서 녹차 추출액 2.0g, 감나무 추출액 1.0g, 모란 추출액 2.0g, 단삼 추출액 0.8g, 마가목 추출액 1.5g, 상황버섯 추출액 2.0g, 비타민 C 1.0g, 프락토 올리고당 11.0g, 복합 황금추출물 0.1g, 나한과 추출물 0.1g, 타우린 0.05g, 폴리덱스트로즈(중합체 90% 이상) 2.5g, 구연산 0.1g, 효소처리 스테비아 0.1g, 정제수 75.65g을 혼합하고, 살균단계 이후에 허브향 0.1g을 혼합하여 기능성 음료를 제조하였다.Green tea extract 2.0g, persimmon extract 1.0g, peony extract 2.0g, Dansam extract 0.8g, rowan extract 1.5g, green mushroom extract 2.0g, vitamin C 1.0g, fructo oligosaccharide 11.0g, complex golden extract 0.1g , Nagwa extract 0.1g, taurine 0.05g, polydextrose (polymer 90% or more) 2.5g, citric acid 0.1g, enzyme-treated stevia 0.1g, purified water 75.65g and after sterilization 0.1g herbal flavor Functional drinks were prepared by mixing.
이상의 각 실시예들에 의해 제조된 기능성 음료에 대하여 관능평가를 실시하였다. 관능평가는 색상, 성상, 맛, 풍미, 종합적 기호도의 다섯 개 항목으로 실시하였으며, 가장 좋음이 5점, 좋음이 4점, 보통이 3점, 나쁨이 2점, 아주 나쁨을 1점으로 하여 산출하였다. 관능평가의 결과는 표 2와 같다.The sensory evaluation was performed on the functional beverage produced by each of the above examples. Sensory evaluation was carried out with five items of color, appearance, taste, flavor and overall preference. The best score was 5 points, good score was 4 points, moderate score was 3 points, bad score was 2 points, and bad score was 1 point. It was. The results of sensory evaluation are shown in Table 2.
[표 2]TABLE 2
이상의 관능평가 결과에 따라 본 발명의 한 실시예에 따른 약용식물 추출액을 이용한 기능성 음료는 상기 실시예 2의 혼합비로 각 성분을 조성하는 것이 가장 바람직하다.According to the above sensory evaluation results, the functional beverage using the medicinal plant extract according to one embodiment of the present invention is most preferably formulated with each component in the mixing ratio of Example 2.
도 1은 본 발명의 한 실시예에 따른 약용식물 추출액을 이용한 기능성 음료 제조방법의 제조 단계를 나타낸 블록도.1 is a block diagram showing the manufacturing steps of the functional beverage manufacturing method using a medicinal plant extract according to an embodiment of the present invention.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090021183A KR20100102890A (en) | 2009-03-12 | 2009-03-12 | Process of manufacture of ability drink that use medicinal plant extraction liquid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090021183A KR20100102890A (en) | 2009-03-12 | 2009-03-12 | Process of manufacture of ability drink that use medicinal plant extraction liquid |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20100102890A true KR20100102890A (en) | 2010-09-27 |
Family
ID=43007752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090021183A KR20100102890A (en) | 2009-03-12 | 2009-03-12 | Process of manufacture of ability drink that use medicinal plant extraction liquid |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20100102890A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101218397B1 (en) * | 2012-04-23 | 2013-01-14 | 선만규 | Citron tea and manufacturing method thereof |
KR101415706B1 (en) * | 2013-10-11 | 2014-07-04 | 김석근 | As Artemisia annua L and Orostachys japonicus A. Berger extract and its application to a method of manufacturing and health food |
CN103947758A (en) * | 2014-04-11 | 2014-07-30 | 洛阳春魁农业开发有限公司 | Preparation method for peony-seed containing flavor beverage |
KR20220168361A (en) | 2021-06-16 | 2022-12-23 | 주식회사 정담푸드 | Method for producing a beverage containing the juice extract of vegetable raw materials |
-
2009
- 2009-03-12 KR KR1020090021183A patent/KR20100102890A/en not_active Application Discontinuation
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101218397B1 (en) * | 2012-04-23 | 2013-01-14 | 선만규 | Citron tea and manufacturing method thereof |
KR101415706B1 (en) * | 2013-10-11 | 2014-07-04 | 김석근 | As Artemisia annua L and Orostachys japonicus A. Berger extract and its application to a method of manufacturing and health food |
CN103947758A (en) * | 2014-04-11 | 2014-07-30 | 洛阳春魁农业开发有限公司 | Preparation method for peony-seed containing flavor beverage |
CN103947758B (en) * | 2014-04-11 | 2016-03-16 | 洛阳春魁农业开发有限公司 | A kind of preparation method containing peony seeds flavor beverage |
KR20220168361A (en) | 2021-06-16 | 2022-12-23 | 주식회사 정담푸드 | Method for producing a beverage containing the juice extract of vegetable raw materials |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101130741B (en) | Vinegar koji and biological edible vinegar, and method of producing the same | |
KR100711224B1 (en) | Method for preparing fermented soybean with chinese herbs | |
KR20180033381A (en) | The producing method of nutritional vinegar | |
KR20100102890A (en) | Process of manufacture of ability drink that use medicinal plant extraction liquid | |
CN107535934A (en) | A kind of Blueberry frozen and preparation method thereof | |
KR102168192B1 (en) | Healthful mixed tea development using fermented herbs, fruits and shiitake | |
KR20100126110A (en) | Manufacturing method for medicinal wine using turmeic thereof medicinal wine | |
KR20020013046A (en) | A functional Doenjang preventing hypertension and kidney trouble and process for preparation thereof | |
KR100994196B1 (en) | Method of preparing fermented liquid of garlic and chonggugjang | |
KR101402852B1 (en) | Fermented bellflower pills and Preparation thereof | |
KR101723402B1 (en) | Method of preparing compositioni containing active ingredient of culture medium of ceriporia lacerata for prevention and improvement of diabetes, diabetic complications disease from diabetes | |
KR20160060834A (en) | Compositions for culture media of Kefir grain comprising plant extract and compositions for improving skin conditions comprising fermented products using the same | |
CN107736542A (en) | A kind of compound lozenge of blueberry and preparation method thereof | |
KR101375347B1 (en) | The method for manufacuting red ginseng drink with medicinal herb, and the red ginseng drink made by the method | |
KR102211523B1 (en) | Pills for health foods and methods for manufacturing same | |
KR101445573B1 (en) | Ferment solution and pill using Cundrania tricuspidata and manufacturing method of that | |
CN108578589B (en) | Composite effervescent tablet for relieving alcoholism and preparation method thereof | |
KR101453061B1 (en) | Ferment solution and pill using mulberry and manufacturing method of that | |
KR102167812B1 (en) | Fermented product of sorghum-adzuki bean mixture for intestinal health and improvement effect of bowel | |
CN107095296B (en) | Method for making selenium-rich red date medlar ginger soup | |
KR20150062553A (en) | Manufacturing method of composition of health food containing Ixeris Dentata extracts and composition of health food containing Ixeris Dentata extracts manufactured by the same | |
CN110679688A (en) | Honey oolong tea beverage | |
KR101581761B1 (en) | Using herbal medicine prescription medicine fermented food production methods | |
KR20180077106A (en) | A composition for improving memory or cognitive function comprising a aurantii fructus immaturus supercritical extract as an active ingredient | |
CN107581609A (en) | A kind of garlic peptide composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |